4 days ago
Austin, TX, USA or South San Francisco, CA, USAEntry Level / Mid Level / Senior
H1B sponsor
Base Salary
$151k - $281k/yr
Responsibilities
- Build and maintain a Hardware-in-the-Loop system using real robot hardware with production software and firmware.
- Write automated HIL tests covering integration, timing, faults, and system bring-up.
- Define pass/fail criteria, coverage requirements, and acceptance criteria.
- Integrate software-in-the-loop, HIL, and hardware acceptance testing into a CI pipeline with logs, traces, and reproducible results.
- Own release-gating tests, reproduce failures that escape simulation or HIL, and close resulting coverage gaps.
Requirements
- Strong Rust skills and Python experience for test tooling and analysis.
- Experience with HIL, test rigs, or system-level verification on robots, vehicles, or similar hardware.
- Comfort working close to drivers, firmware, and hardware buses.
- Experience debugging asynchronous and concurrent systems, RPC, telemetry, and timing failures across software and firmware.
- Experience building automated test pipelines.
- Bazel experience is preferred.
- Ability to use AI agents to accelerate work while maintaining quality.
- Strong focus on repeatability, edge cases, and traceability.
Benefits
- Full-time employees receive medical, dental, and vision insurance through a PPO plan.
- Paid holidays, commuter benefits, meals, equity compensation in the form of RSUs, a 401(k) plan, parental leave, and flexible time off are offered, with stated exclusions for temporary employees and interns.
- The role offers growth potential and the opportunity to work with experts across multiple fields.
About Neuralink
Neuralink builds implantable brain–computer interfaces and a neurosurgical robot to read and stimulate neural activity for medical and assistive uses. The privately held company, founded in 2016 and headquartered in Austin, develops a wireless implant and software enabling people with paralysis to control computers and external devices; it has FDA Breakthrough Device designations and began human clinical trials. Its business model centers on regulated medical devices sold through healthcare providers and research partnerships.